← Leaderboards
Michael Marmor
New York University School Of Medicine
$8,655,715
Attributed
$8,655,715
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $991.8K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$7,033,236 · 9
CDC$1,622,479 · 2
By mechanism
P30$2,299,298 · 3
P01$2,163,117 · 1
R01$1,886,840 · 1
U01$1,622,479 · 2
M01$683,981 · 4
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Simon Karpatkin$8,225,232
- Iman Osman$8,470,073
- William Borkowsky$9,487,417
- William N Rom$26,662,104
- Michael D. Weiden$9,969,115
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsHuman SubjectClinical ResearchEpidemiologyClinical TrialsHuman Therapy EvaluationBehavioral /Social Science Research TagStatistics /BiometryIntravenous Drug AbuseAids VaccinesHuman Immunodeficiency VirusMathematical ModelDisease /Disorder Proneness /RiskHuman Immunodeficiency Virus 1Recruitment ActivityResearch PersonnelServicesHigh Risk Behavior /LifestyleBiometryHealth BehaviorAcutePatient Oriented ResearchCollectionEnrollment
Grant awards (35)
World Trade Center Exposures, Neuropathic Symptoms and Nervous System Injury$349,102
U01 · FY2017 · OH · contact PI
World Trade Center Exposures, Neuropathic Symptoms and Nervous System Injury$349,187
U01 · FY2016 · OH · contact PI
Trace Elements in Autopsy Tissues from World Trade Center Decedents$454,064
U01 · FY2014 · OH · contact PI
Trace Elements in Autopsy Tissues from World Trade Center Decedents$470,126
U01 · FY2013 · OH · contact PI
Clinical Core$173,029
P30 · FY2010 · AI · contact PI
CLINICAL CORE$488,515
P30 · FY2009 · AI · contact PI
CLINICAL CORE$515,584
P30 · FY2008 · AI · contact PI
Core--Recruitment, epidemiology and biostatistics$476,208
P01 · FY2008 · AI · contact PI
Core--Recruitment, epidemiology and biostatistics$479,835
P01 · FY2007 · AI · contact PI
CLINICAL CORE$323,611
P30 · FY2007 · AI · contact PI
Core--Recruitment, epidemiology and biostatistics$489,855
P01 · FY2006 · AI · contact PI
CLINICAL CORE$320,595
P30 · FY2006 · AI · contact PI
Core--Recruitment, epidemiology and biostatistics$475,008
P01 · FY2005 · AI
CLINICAL CORE$306,889
P30 · FY2005 · AI
DRUG ABUSE, DEPRESSION AND RESPONSES TO HIV COUNSELING$177,830
M01 · FY2005 · RR
Drug Abuse, Depression and Responses to HIV Counseling$591,947
R01 · FY2004 · DA
Drug Abuse, Depression and Responses to HIV Counseling$443,133
M01 · FY2004 · RR
Core--Recruitment, epidemiology and biostatistics$242,211
P01 · FY2004 · AI
Drug Abuse, Depression and Responses to HIV Counseling$666,983
R01 · FY2003 · DA
Drug Abuse, Depression and Responses to HIV Counseling$627,910
R01 · FY2002 · DA
HIV VACCINE PREPAREDNESS STUDY AND EFFICACY TRIAL$0
M01 · FY2002 · RR
TUBERCULOSIS IN A MULTIETHNIC CITY POPULATION$0
M01 · FY2002 · RR
CORE--CLINICAL FACILITY$0
P30 · FY2002 · AI
CANARYPOX ALVAC-HIV VCP205 VACCINE IN HIV-INFECTED ADULTS$0
M01 · FY2002 · RR
CORE--CLINICAL FACILITY$171,075
P30 · FY2001 · AI
HIV VACCINE PREPAREDNESS STUDY AND EFFICACY TRIAL$0
M01 · FY2001 · RR
CORE--CLINICAL FACILITY$0
P30 · FY2001 · AI
CANARYPOX ALVAC-HIV VCP205 VACCINE IN HIV-INFECTED ADULTS$0
M01 · FY2001 · RR
TUBERCULOSIS IN A MULTIETHNIC CITY POPULATION$0
M01 · FY2001 · RR
TUBERCULOSIS IN A MULTIETHNIC CITY POPULATION$21,006
M01 · FY2000 · RR
CANARYPOX ALVAC-HIV VCP205 VACCINE IN HIV-INFECTED ADULTS$21,006
M01 · FY2000 · RR
HIV VACCINE PREPAREDNESS STUDY AND EFFICACY TRIAL$21,006
M01 · FY2000 · RR
TUBERCULOSIS IN A MULTIETHNIC CITY POPULATION$0
M01 · FY2000 · RR
HIV VACCINE PREPAREDNESS STUDY AND EFFICACY TRIAL$0
M01 · FY2000 · RR
CANARYPOX ALVAC-HIV VCP205 VACCINE IN HIV-INFECTED ADULTS$0
M01 · FY2000 · RR